Health
‘Stretched’ Vic hospital pleads for staff – Forbes Advocate
An Australian-first trial aims to “once and for all” settle the science surrounding an antimalarial drug touted by US President Donald Trump as protection fro…
An Australian-first trial aims to “once and for all” settle the science surrounding an antimalarial drug touted by US President Donald Trump as protection from COVID-19.
The “COVID shield” study, led by Melbourne’s Walter and Eliza Hall Institute, has recruited more than 100 healthcare workers to test the efficacy of hydroxychloroquine.
Study co-lead Marc Pellegrini said half of study participants would be given the drug and the rest a placebo tablet over a four-month span to determine its eff…
-
Noosa News21 hours agoExperts share tiny home warning as interest from young people soars
-
Noosa News20 hours agoExpert’s warning as tourists stunned by hundreds of sharks spotted close to shore at Moreton Island, Queensland
-
General17 hours agoConvicted mushroom murderer Erin Patterson outlines her reasons to appeal
-
Noosa News19 hours agoSeven people arrested in counter-terrorism sting in regional Queensland